A detailed history of Wms Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wms Partners, LLC holds 1,547 shares of LLY stock, worth $1.37 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,547
Previous 1,564 1.09%
Holding current value
$1.37 Million
Previous $1.22 Million 15.13%
% of portfolio
0.09%
Previous 0.09%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $12,322 - $15,453
-17 Reduced 1.09%
1,547 $1.4 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $246,947 - $330,380
-417 Reduced 21.05%
1,564 $1.22 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $605,018 - $713,237
-1,152 Reduced 36.77%
1,981 $1.15 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $57,380 - $79,107
-132 Reduced 4.04%
3,133 $1.68 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $1,052 - $1,406
3 Added 0.09%
3,265 $1.53 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $22,986 - $26,996
-74 Reduced 2.22%
3,262 $1.12 Million
Q4 2022

Feb 07, 2023

SELL
$321.55 - $374.67 $36,978 - $43,087
-115 Reduced 3.33%
3,336 $1.22 Million
Q3 2022

Nov 08, 2022

BUY
$296.48 - $337.87 $16,306 - $18,582
55 Added 1.62%
3,451 $1.12 Million
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $336,148 - $394,687
-1,206 Reduced 26.21%
3,396 $1.1 Million
Q1 2022

May 10, 2022

BUY
$234.69 - $291.66 $220,608 - $274,160
940 Added 25.67%
4,602 $1.32 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $4,946 - $6,138
22 Added 0.6%
3,662 $1.01 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $16,176 - $19,907
-73 Reduced 1.97%
3,640 $841,000
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $12,638 - $16,347
-70 Reduced 1.85%
3,713 $852,000
Q4 2020

Feb 17, 2021

BUY
$130.46 - $172.63 $1,695 - $2,244
13 Added 0.34%
3,783 $639,000
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $34,787 - $41,865
-255 Reduced 6.34%
3,770 $619,000
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $22,024 - $27,259
-185 Reduced 4.39%
4,025 $558,000
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $21,597 - $26,750
-202 Reduced 4.58%
4,210 $553,000
Q3 2019

Nov 07, 2019

BUY
$106.79 - $116.16 $2,883 - $3,136
27 Added 0.62%
4,412 $493,000
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $138,487 - $161,650
-1,250 Reduced 22.18%
4,385 $486,000
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $38,958 - $45,857
350 Added 6.62%
5,635 $731,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $4,553 - $5,101
43 Added 0.82%
5,285 $612,000
Q2 2018

Aug 09, 2018

SELL
$75.7 - $86.88 $65,480 - $75,151
-865 Reduced 14.16%
5,242 $447,000
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $5,565 - $6,570
-75 Reduced 1.21%
6,107 $472,000
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $74,073 - $79,452
904 Added 17.13%
6,182 $522,000
Q3 2017

Oct 27, 2017

SELL
$77.07 - $85.54 $2,389 - $2,651
-31 Reduced 0.58%
5,278 $451,000
Q2 2017

Aug 09, 2017

BUY
N/A
5,309
5,309 $437,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wms Partners, LLC Portfolio

Follow Wms Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.